CVS Health announced this week that its pharmacies will begin dispensing prescription medications for dogs and cats — a small headline with real implications for anyone holding, buying, or selling a CVS net lease property. The program is live at more than 9,000 CVS Pharmacy locations nationwide, which is effectively the entire operating fleet.

What CVS Actually Announced

Pet owners can now fill common veterinary prescriptions at their local CVS counter. Covered categories include antibiotics, allergy medications, flea and tick treatments, insulin, and pain relievers.

The mechanics are straightforward: a pet owner brings in a written prescription from their veterinarian, or the vet transmits it directly to the pharmacy. From there, the prescription behaves like any other — customers can pick it up in store, and select medications qualify for home delivery. Eligible pet prescriptions also plug into existing CVS pharmacy services such as automatic refills and prescription synchronization.

Pets can be added to a CVS.com profile and managed through the CVS Health app. The company said electronic prescribing tools for veterinarians will follow in the coming months.

CVS is not first to this. Publix, Costco, Walmart, and Walgreens already offer pet prescription fills, which makes this less a land grab than a defensive catch-up.

Why NNN Investors Should Care

The drugstore sector has spent the last several years under a cloud. Store closures at Rite Aid and Walgreens, mail-order and Amazon pressure on front-of-store margins, and reimbursement compression have all widened pharmacy cap rates relative to where they traded a decade ago. Buyers underwriting a 15- or 20-year CVS lease today are, whether they say it out loud or not, underwriting one question: will this box still be a pharmacy in year twelve?

Pet prescriptions are a modest revenue line. But they are a signal about store-level strategy, and that is what matters to a landlord. Three takeaways:

1. It reinforces the physical footprint. Pet meds are a category that requires a counter, a pharmacist, and a reason to walk in. Every service CVS layers onto the physical store — vaccinations, MinuteClinic, testing, now veterinary fills — raises the cost of closing that location and lengthens the practical life of the real estate.
2. It drives incremental trips. Pet medication is recurring by nature, and recurring trips support front-of-store sales — which are what keep marginal locations above the closure threshold.
3. It sharpens the gap between good and bad boxes. Strategy shifts like this help strong-performing stores more than weak ones. For investors, that means the underwriting work — sales per store where available, trade-area demographics, competing pharmacy count within a mile, real estate value independent of the lease — matters more than the headline cap rate, not less.

The Practical Read

One announcement does not reprice a sector. Investors evaluating a single-tenant net lease pharmacy should still anchor on lease term remaining, rent-to-market, corporate guarantee, and the fundamental question of what the building is worth if the tenant walks. CVS remains an investment-grade credit with one of the deepest tenant profiles in net lease, and incremental moves that make the physical store harder to close are directionally good news for landlords.

For sellers, it is a useful talking point in a market where drugstore buyers have been asking hard questions. For buyers, it is one more reason to look closely at pharmacy assets that have been priced for pessimism.

Silber Investment Properties’ National Net Lease Division has closed hundreds of pharmacy transactions, including a 14-store CVS portfolio valued at over $40 million. Read our CVS tenant profile or compare with our Walgreens tenant profile for current lease structures and cap rate ranges. To discuss valuation on a property you own, contact our net lease team.